Antares Therapeutics

Antares Therapeutics is a biotechnology company dedicated to developing transformative, first-in-class precision medicines, focusing on proven, undruggable targets in cancer and other serious diseases with significant unmet needs. Antares' most advanced program is expected to enter clinical trials in 2026, with multiple other programs in preclinical development.